Live from the NIH registry
Studies recruiting near Oceanside right now
Top 25 of 712 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
University of California San Diego Moores Cancer Center (Adults only) — La Jolla, California (26.2 mi)
· Sponsor: Pierre Fabre Medicament
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of California San Diego — La Jolla, California (26.2 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 25 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Francisco
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
San Diego Neurosurgery — Encinitas, California (13.0 mi)
· Sponsor: Collagen Matrix
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
UCSD Altman Clinical and Translational Research Institute Building — La Jolla, California (26.2 mi)
· Sponsor: Amgen
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
Scripps Clinic Torrey Pines — La Jolla, California (26.2 mi)
· Sponsor: Pfizer
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Urinary Tract Infection, Recurrent
Phase 1, Phase 2
Interventional 32 participants sought
University of California, San Diego — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Diego
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50257 — La Jolla, California (26.2 mi)
· Sponsor: UCB Biopharma SRL
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Headlands Research California, LLC — Escondido, California (14.8 mi)
· Sponsor: Medtronic MiniMed, Inc.
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — La Jolla, California (26.2 mi)
· Sponsor: Salma Health, Inc.
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
UCSD - Altman Clinical and Translational Research Institute (ACTRI) — La Jolla, California (26.2 mi)
· Sponsor: Eli Lilly and Company
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Profound Research — Oceanside, California (4.6 mi)
· Sponsor: Alveus Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-San Marcos — San Marcos, California (10.0 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Phase 2
Interventional 75 participants sought
Moores Cancer Center at UC San Diego /ID# 230157 — La Jolla, California (26.2 mi)
· Sponsor: AbbVie
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma
Phase 1, Phase 2
Interventional 97 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Alzheimers Disease, Dementia
Phase 2, Phase 3
Interventional 280 participants sought
University of California San Diego Medical Center — La Jolla, California (26.2 mi)
· Sponsor: Washington University School of Medicine
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
University of California, San Diego — La Jolla, California (26.2 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
NSCLC (Advanced Non-small Cell Lung Cancer)
Phase 1, Phase 2
Interventional 675 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: BlossomHill Therapeutics
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Kaiser Permanente - San Marcos — San Marcos, California (10.0 mi)
· Sponsor: Hoffmann-La Roche
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: Daiichi Sankyo
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Belly Pain, GI Health
N/A
Interventional 825 participants sought
Radicle Science Inc. — Del Mar, California (18.5 mi)
· Sponsor: Radicle Science
Allograft Dysfunction in Heart Transplant
Heart Transplant Failure and Rejection
Phase 4
Interventional 376 participants sought
UC San Diego — La Jolla, California (26.2 mi)
· Sponsor: Paul Kim
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Cadena Care Inst. — Poway, California (24.0 mi)
· Sponsor: Regeneron Pharmaceuticals